Skip to Content

Nebivolol

In the US, Nebivolol (nebivolol systemic) is a member of the drug class cardioselective beta blockers and is used to treat High Blood Pressure and Mitral Valve Prolapse.

US matches:

UK matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

C07AB12

CAS registry number (Chemical Abstracts Service)

0099200-09-6

Chemical Formula

C22-H25-F2-N-O4

Molecular Weight

405

Therapeutic Categories

Antihypertensive agent

β-adrenoceptor antagonist (beta blocker), cardioselective

Treatment of heart failure (adjunct)

Chemical Name

2H-1-Benzopyran-2-metanol, α,α'-[iminobis(metylene)]bis[6-fluoro-3,4-dihydro-

Foreign Names

  • Nebivololum (Latin)
  • Nebivolol (German)
  • Nebivolol (French)
  • Nebivolol (Spanish)

Generic Names

Brand Names

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
BANMBritish Approved Name (Modified)
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide